HELICOBACTER-PYLORI AND EPSTEIN-BARR-VIRUS INFECTION AND THE P53 TUMOR-SUPPRESSOR PATHWAY IN GASTRIC STUMP CANCER COMPARED WITH CARCINOMA IN THE NONOPERATED STOMACH
Io. Baas et al., HELICOBACTER-PYLORI AND EPSTEIN-BARR-VIRUS INFECTION AND THE P53 TUMOR-SUPPRESSOR PATHWAY IN GASTRIC STUMP CANCER COMPARED WITH CARCINOMA IN THE NONOPERATED STOMACH, Journal of Clinical Pathology, 51(9), 1998, pp. 662-666
Aim-To evaluate similarities and differences between gastric stump can
cer and conventional carcinoma in the nonoperated stomach. Methods-26
stump carcinomas were compared with 24 conventional stomach cancers. S
tage, histological type, and demographics were comparable in the two g
roups. Expression of p53 and p21-Waf1/Cip1 was evaluated by immunohist
ochemical staining. Helicobacter pylori infection was evaluated by exa
mining haematoxylin-eosin stained slides and immunohistochemistry. Eps
tein-Barr virus infection was evaluated by RNA in situ hybridisation.
Results-Expression of p53 and p21-Waf1/Cip1 was similar in both groups
and positive in more than half of the patients. Helicobacter pylori i
nfection was observed in six stump carcinomas and 17 conventional carc
inomas in the intact stomach (p < 0.01). RNA in situ hybridisation (EB
ER1-ISH) for Epstein-Barr virus was positive in nine stump carcinomas
and two carcinomas in the non-operated stomach (p < 0.05). Conclusions
-There appear to be aetiological differences between stump carcinoma a
nd cancer in the intact stomach. Further study of these differences ma
y improve our understanding of gastric carcinogenesis in general.